RECENT ADVANCES IN THE DIAGNOSIS, RISK STRATIFICATION, AND PERSONALIZED MANAGEMENT OF DIFFERENTIATED THYROID CANCER: A FIVE-YEAR LITERATURE REVIEW

Differentiated thyroid cancer (DTC) represents the most prevalent endocrine malignancy and includes papillary, follicular, and oncocytic thyroid carcinomas. Despite generally favorable survival outcomes, disease persistence, recurrence, and radioiodine resistance remain important clinical challenges. Recent advances in molecular diag-nostics, histopathological classification, and risk-adapted treatment have substantially transformed approaches to DTC management.